CN108078909A - Stem cell toner - Google Patents
Stem cell toner Download PDFInfo
- Publication number
- CN108078909A CN108078909A CN201810032109.1A CN201810032109A CN108078909A CN 108078909 A CN108078909 A CN 108078909A CN 201810032109 A CN201810032109 A CN 201810032109A CN 108078909 A CN108078909 A CN 108078909A
- Authority
- CN
- China
- Prior art keywords
- component
- extract
- stem cell
- mass ratio
- lotion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 106
- 239000000284 extract Substances 0.000 claims abstract description 197
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 83
- 239000004909 Moisturizer Substances 0.000 claims abstract description 31
- 230000001333 moisturizer Effects 0.000 claims abstract description 31
- 239000006210 lotion Substances 0.000 claims description 125
- 240000002853 Nelumbo nucifera Species 0.000 claims description 114
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 112
- 210000004027 cell Anatomy 0.000 claims description 60
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 51
- 239000000843 powder Substances 0.000 claims description 47
- 239000003906 humectant Substances 0.000 claims description 42
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 claims description 41
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 claims description 40
- 229940106189 ceramide Drugs 0.000 claims description 39
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 37
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 37
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims description 37
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 37
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 37
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 35
- 102000007644 Colony-Stimulating Factors Human genes 0.000 claims description 35
- 108010071942 Colony-Stimulating Factors Proteins 0.000 claims description 35
- 229940005581 sodium lactate Drugs 0.000 claims description 35
- 239000001540 sodium lactate Substances 0.000 claims description 35
- 235000011088 sodium lactate Nutrition 0.000 claims description 35
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 30
- 229920002674 hyaluronan Polymers 0.000 claims description 30
- 229960003160 hyaluronic acid Drugs 0.000 claims description 30
- 102000008186 Collagen Human genes 0.000 claims description 27
- 108010035532 Collagen Proteins 0.000 claims description 27
- 229960005188 collagen Drugs 0.000 claims description 27
- 229920001436 collagen Polymers 0.000 claims description 27
- 241000222290 Cladosporium Species 0.000 claims description 26
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 18
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 18
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 18
- 241000980780 Cladosiphon okamuranus Species 0.000 claims description 9
- 241000775848 Syringa oblata Species 0.000 claims description 9
- 239000008213 purified water Substances 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- 210000002514 epidermal stem cell Anatomy 0.000 claims description 5
- 241000980781 Cladosiphon Species 0.000 claims description 3
- 210000003491 skin Anatomy 0.000 abstract description 51
- 230000000694 effects Effects 0.000 abstract description 17
- 210000002615 epidermis Anatomy 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 3
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- 241000258957 Asteroidea Species 0.000 abstract 1
- 241000195493 Cryptophyta Species 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 description 132
- 229920000742 Cotton Polymers 0.000 description 103
- 238000003860 storage Methods 0.000 description 70
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 48
- 239000007788 liquid Substances 0.000 description 42
- 241001104043 Syringa Species 0.000 description 32
- 235000004338 Syringa vulgaris Nutrition 0.000 description 31
- SFAIBBNGVDULCN-UHFFFAOYSA-K aluminum;2-oxopyrrolidine-1-carboxylate Chemical compound [Al+3].[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O.[O-]C(=O)N1CCCC1=O SFAIBBNGVDULCN-UHFFFAOYSA-K 0.000 description 21
- 239000000835 fiber Substances 0.000 description 17
- 235000011187 glycerol Nutrition 0.000 description 17
- 229940064064 purslane extract Drugs 0.000 description 16
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- 210000002919 epithelial cell Anatomy 0.000 description 12
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 11
- 241000395107 Cladosporium cucumerinum Species 0.000 description 10
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 9
- 230000010261 cell growth Effects 0.000 description 9
- 239000005639 Lauric acid Substances 0.000 description 7
- 244000223014 Syzygium aromaticum Species 0.000 description 7
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 239000007921 spray Substances 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 210000002540 macrophage Anatomy 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 230000001172 regenerating effect Effects 0.000 description 6
- 230000036555 skin type Effects 0.000 description 6
- 230000004936 stimulating effect Effects 0.000 description 6
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 5
- 235000021360 Myristic acid Nutrition 0.000 description 5
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 229940087603 grape seed extract Drugs 0.000 description 5
- 235000002532 grape seed extract Nutrition 0.000 description 5
- 239000003102 growth factor Substances 0.000 description 5
- 239000006166 lysate Substances 0.000 description 5
- 239000001717 vitis vinifera seed extract Substances 0.000 description 5
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 4
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 4
- 241000208317 Petroselinum Species 0.000 description 4
- 241000235346 Schizosaccharomyces Species 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 229940043259 farnesol Drugs 0.000 description 4
- 229930002886 farnesol Natural products 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 229960005150 glycerol Drugs 0.000 description 4
- 235000011197 perejil Nutrition 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- -1 tissue engineering Substances 0.000 description 4
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 3
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 3
- 244000234609 Portulaca oleracea Species 0.000 description 3
- 235000001855 Portulaca oleracea Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 239000011570 nicotinamide Substances 0.000 description 3
- 229960003966 nicotinamide Drugs 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- 241001247197 Cephalocarida Species 0.000 description 2
- 241000190633 Cordyceps Species 0.000 description 2
- 241001226187 Cyrtomium fortunei Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000005807 Nelumbo Nutrition 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010039710 Scleroderma Diseases 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 230000032823 cell division Effects 0.000 description 2
- 150000001783 ceramides Chemical class 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000009965 odorless effect Effects 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 239000001133 paullinia cupana hbk gum Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003408 sphingolipids Chemical class 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- FQCSIUSICFAMDD-UHFFFAOYSA-N 2-oxopyrrolidine-1-carboxylic acid;sodium Chemical compound [Na].OC(=O)N1CCCC1=O FQCSIUSICFAMDD-UHFFFAOYSA-N 0.000 description 1
- 241000221635 Cladonia Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241001098499 Lanceolata Species 0.000 description 1
- 229920000433 Lyocell Polymers 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000000569 Musa basjoo Species 0.000 description 1
- 235000000139 Musa basjoo Nutrition 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 241000155666 Siphonostegia Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 244000042324 Trifolium repens Species 0.000 description 1
- 235000013540 Trifolium repens var repens Nutrition 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000001556 apium graveolens l. seed extract Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229940116732 celery seed extract Drugs 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 230000009786 epithelial differentiation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a kind of stem cell toner, including 0.05~0.2 part of 55~95 parts of component A, 10~15 parts of B component and component C；Wherein, the component A includes moisturizer and water；The B component includes starfish branch tube algae extract；And the component C includes stem cell.Above-mentioned stem cell toner, it is small to skin irritation, the skin of various different skin quality is generally applicable to, can reach crease-resistant, repair epidermis and regenerate the technique effect of skin.
Description
Technical Field
The invention relates to the field of application of Cladosiphon okamuranus Dunn, in particular to stem cell toning lotion.
Background
The cosmetic water is generally transparent liquid, and can remove dirt and oily secretion on skin, keep stratum corneum of skin with appropriate water content, promote skin physiological function, soften skin and prevent pachylosis. The lotions are classified into skin lotions, astringent lotions, soft lotions, and the like, and have different orientations and different designs, so that a large number of different lotions are available on the market.
Lotions are generally used in two situations: after the face is cleaned and before makeup, the face water can be supplemented properly, pores can be shrunk, and other cosmetics such as honey powder, eye shadow and the like can be easily adsorbed by the skin during makeup; or after makeup removal, for shrinking pores on the skin and for slightly cleansing the skin, especially the residues of other cosmetics on the face.
The main function of the lotion is not to wash off the residual cleansing milk, nor to make the user's skin feel burning or to shrink pores. The essential task of the lotion is to restore the natural ph of the user's skin, ready for the next skin care step. If your facial cleaning product is unable to do its job and does not wash the cosmetics and dirt clean, the user should do a change to a facial cleaning product instead of simply remedying with lotion.
Cladosiphon okamuranus (Cladosiphon NOVAE-calmetoniae) is one of Cladosiphon okamuranus, and has been studied in the field of cosmeceutical, and the applicant is conducting research and development on the application of Cladosiphon okamuranus to stem cells in the cosmetic lotion field.
Disclosure of Invention
Based on this, there is a need for a stem cell lotion.
A stem cell toning lotion comprises 55-95 parts of a component A, 10-15 parts of a component B and 0.05-0.2 part of a component C; wherein the component A comprises a humectant and water; the component B comprises Cladosiphon okamuranus extract; and, the C fraction comprises stem cells.
In one embodiment, the component B further comprises a excrementum passeris extract, lotus flower oil, lotus root powder and a cordyceps sinensis extract, and the mass ratio of the siphonostegia asteroides extract, the excrementum passeris extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract in the component B is 4-8: "1-4": 1-3 ": 0.5-1".
In one embodiment, the component B further comprises a cell colony stimulating factor and tridecapeptide-1, and the mass ratio of the cladosporium asteroides extract, the cell colony stimulating factor and the tridecapeptide-1 in the component B is 4-8: 0.02-0.3: 0.01-0.2.
In one embodiment, the component B also comprises a lotus rhizome extract, and the mass ratio of the cladosporium asteroides extract to the lotus rhizome extract in the component B is 4-8: 1-2.
In one embodiment, in the C fraction, the stem cells are epidermal stem cells.
In one embodiment, the mass ratio of the humectant to the water in the component A is 5-10: 50-85.
In one embodiment, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, collagen, and/or chondroitin sulfate.
In one embodiment, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid and collagen in a mass ratio of 0.2-1.5 ": 1-2": 0.05-0.1 ": 0.5-1": 1-4 ".
In one embodiment, in the component a, the water is purified water.
In one embodiment, in the a component, the water is deionized water.
The stem cell toning lotion has small irritation to skin, is generally suitable for skin of various skin types, and can achieve the technical effects of resisting wrinkles, repairing epidermis and regenerating skin.
In other embodiments, the stem cell lotion has excellent moisturizing effect by adopting a matching design of combining the epidermal layer humectant and the dermal layer humectant, can also realize whitening and other effects, and has a certain antibacterial effect.
Drawings
FIG. 1 is a schematic diagram of one embodiment of the present invention.
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention comprehensible, embodiments accompanied with figures are described in detail below. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
It will be understood that when an element is referred to as being "secured to" or "disposed on" another element, it can be directly on the other element or intervening elements may also be present. When an element is referred to as being "connected" to another element, it can be directly connected to the other element or intervening elements may also be present. The terms "vertical," "horizontal," "left," "right," and the like as used herein are for illustrative purposes only and do not represent the only embodiments.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terminology used in the description of the invention herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
One embodiment of the invention is stem cell toning lotion, which comprises 55-95 parts of a component A, 10-15 parts of a component B and 0.05-0.2 part of a component C; wherein the component A comprises a humectant and water; the component B comprises Cladosiphon okamuranus extract; and, the C fraction comprises stem cells. For example, the stem cell lotion comprises 60-90 parts of a component A, 11-14 parts of a component B and 0.07-0.18 part of a component C; for another example, the stem cell toning lotion comprises 70-80 parts of the component A, 12-13 parts of the component B and 0.1-0.15 part of the component C; for another example, the stem cell lotion comprises 55 parts of the component A, 10 parts of the component B and 0.05 part of the component C; for another example, the stem cell lotion comprises 95 parts of component A, 15 parts of component B and 0.2 part of component C; for another example, the stem cell lotion comprises 55 parts of the component A, 15 parts of the component B and 0.2 part of the component C; for another example, the stem cell lotion comprises 95 parts of component A, 10 parts of component B and 0.05 part of component C; for another example, the stem cell lotion comprises 60 parts of the component A, 14 parts of the component B and 0.18 part of the component C; for another example, the stem cell lotion comprises 70 parts of a component A, 12 parts of a component B and 0.15 part of a component C; for another example, the stem cell lotion comprises 80 parts of component A, 13 parts of component B and 0.1 part of component C. The rest of the examples are analogized. The stem cell toning lotion has small irritation to skin, is generally suitable for skin of various skin types, and can achieve the technical effects of resisting wrinkles, repairing epidermis and regenerating skin.
The cladodiosporium asteroides extract, i.e. the cladodiosporium asteroides extract, may be the extract of the whole cladodiosporium asteroides, or may be the extract of a part of cladodiosporium asteroides, e.g. the cladodiosporium asteroides extract with a part of plastids removed, and so on in the other embodiments. In the examples of the present invention, the term "part by mass" means "g, mg, kg, jin, kg, pound, ton, etc. In grams as an example, 1 part is a certain mass of 0.0001 to 10000 grams; for example, 1 part may be 0.001g, 0.01g, 0.02g, 0.05g, 0.1g, 0.2g, 0.5g, 1g, 2g, 3g, 4g, 5g, 10g, 15g, 20g, 30g, 50g, 80g, 100g, 500g, 1000g, 5000g, 10000g, 50000g, or the like, and is not limited thereto, and may be selected depending on actual production and production, and the like may be applied to each example. For example, 1 part is 1g, and 0.1 part is 0.1 g; for another example, 1 part is 10g, and 0.1 part is 1g, and so on. Furthermore, the extracts of the present invention and its various embodiments, including but not limited to the cladosporium asterium nakai extract, the lilac alba extract, the lotus rhizome extract and/or the purslane extract, can be extracted by pressing, juicing, extracting, centrifuging or distilling, and the concentration can be adjusted according to requirements or experiments, for example, the extract can be solid powder, solid granule or liquid, and the present invention and its various embodiments do not limit this additionally, and preferably the extract is powder granule with a particle size of less than 25 μm, that is, it can pass through a 500 mesh sieve, so that the cladosporium asterium extract of the present invention and its various embodiments has a large number of small molecules, and can permeate deeply into the skin to effectively repair, thereby having the effects of repairing epidermis and regenerating the skin.
In one embodiment, in the component a, the water is purified water. Alternatively, the water is deionized water. In one embodiment, in the component A, the mass ratio of the humectant to the water is 5-10 to 50-85; further, in the component A, the mass ratio of the humectant to the water is 6: '50-85'; wherein 6: 50-85 can also be expressed as 6: 50-6: 85, 6 (50-85) or 6: 50-85, it can be understood that the essence of the four expression ways is the same, that is, when the humectant is 6 parts by mass, 50-85 parts by mass of water, and so on in the other embodiments. For example, in each embodiment, the mass ratio of the humectant to the water in the component A is 5-10: 50-85. For example, in each example, the mass ratio of the humectant to the water in the component a is 5:50, 6:70, 7:60, 8:70, 9:85, 6:73, 7:59, 8:61, 10:85, or the like. Different proportions can produce stem cell toning lotion with different moisturizing efficacies, and is suitable for being made into diversified product lines. For example, the stem cell toning lotion comprises 56 parts of a component A, 11 parts of a component B and 0.1 part of a component C, wherein the mass ratio of the humectant to the water in the component A is 6:50, namely 6 parts of the humectant and 50 parts of the water in the component A, and the like in the rest of examples.
In one embodiment, the moisturizer comprises sodium pyrrolidone carboxylate (PCA-Na), sodium lactate, ceramide, hyaluronic acid, collagen, and/or chondroitin sulfate. For example, the moisturizer includes sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, collagen, or chondroitin sulfate. In one embodiment, the humectant comprises sodium pyrrolidone carboxylate and sodium lactate in a mass ratio of 0.2-1.5 to 1-2; as another example, the moisturizer includes sodium pyrrolidone carboxylate and sodium lactate in a mass ratio of 0.5: 1.5. In one embodiment, the humectant comprises sodium pyrrolidone carboxylate; sodium pyrrolidone carboxylate, also called pyroglutamic sodium glutamate, is colorless, odorless, transparent and slightly salty liquid, is a main component of natural moisturizing factor NMF in skin, and has strong moisturizing effect. Although the maximum water carrying capacity of the gel is only about 3 times of the self weight, the gel has the advantages that the efficacy is close to that of hyaluronic acid in practical application and is far better than that of glycerin, propylene glycol and sorbitol, the viscosity of the sodium pyrrolidone carboxylate is very low, the gel does not have the sticky and heavy feeling of other humectants such as glycerin, the safety is very high, the high concentration of the gel does not stimulate eye and conjunctiva, and the gel is very mild to skin. In addition, the sodium pyrrolidone carboxylate has strong long-term moisture retention, the water content can still reach 60 percent when the sodium pyrrolidone carboxylate is measured after the sodium pyrrolidone carboxylate is placed for 1 month in an environment with the humidity of 65 percent, the sodium pyrrolidone carboxylate is a real physiologically-acting horny layer softening agent, and the stem cell toning lotion is beneficial to avoiding the skin from becoming dry and rough by adopting a proper amount of sodium pyrrolidone carboxylate. Further, the humectant also comprises aluminium pyrrolidone carboxylate (PCA-Al), the mass ratio of the aluminium pyrrolidone carboxylate to the sodium pyrrolidone carboxylate is 0.1-0.5 to 0.2-1.5, for example, the humectant comprises the aluminium pyrrolidone carboxylate to the sodium pyrrolidone carboxylate, and the mass ratio of the aluminium pyrrolidone carboxylate to the sodium pyrrolidone carboxylate is 0.2: 0.5; for example, in the moisturizer, the mass ratio of the aluminum pyrrolidone carboxylate to the sodium pyrrolidone carboxylate is 0.2: 0.5; thus, the stem cell lotion has the effects of shrinking pores, suppressing sweating and disinfecting, and has no irritation to the skin. For example, the moisturizer comprises aluminum pyrrolidone carboxylate, sodium pyrrolidone carboxylate and sodium lactate in a mass ratio of "0.1-0.5": 0.2-1.5 ": 1-2"; for another example, the moisturizer comprises aluminum pyrrolidone carboxylate, sodium pyrrolidone carboxylate and sodium lactate in a mass ratio of 0.2:0.5: 1.5. The stem cell cosmetic water containing sodium lactate has good moisturizing and antibacterial effects, and also has certain adjuvant treatment effect on pox.
In one embodiment, the humectant comprises sodium pyrrolidone carboxylate, sodium lactate and ceramide in a mass ratio of 0.2-1.5 ": 1-2": 0.05-0.1 "; for another example, the moisturizer comprises 0.1-0.5 mass percent of aluminum pyrrolidone carboxylate, 0.2-1.5 mass percent of sodium pyrrolidone carboxylate, 1-2 mass percent of sodium pyrrolidone carboxylate, 0.05-0.1 mass percent of sodium lactate and ceramide. For another example, the moisturizer comprises aluminum pyrrolidone carboxylate, sodium lactate and ceramide in a mass ratio of 0.5:1:2: 0.1. Ceramide (ceramide) is a lipid present in the skin. Also known as sphingolipids, play an important role in the formation of the stratum corneum of the epidermis. Ceramides are a common structural unit for sphingolipids. Topical application of ceramide results in a very significant increase in skin conductance, and secondly, cholesterol, free fatty acids and cholesterol esters do not act significantly. Ceramides have a strong ability to associate with water molecules, and they maintain skin moisture by forming a network in the stratum corneum. In addition, the ceramide content in the horny layer of the epidermis can be increased by using the ceramide, and the conditions of dry skin, desquamation, roughness and the like can be improved; meanwhile, ceramide can increase the thickness of the horny layer of epidermis, improve the water holding capacity of the skin, reduce wrinkles, enhance the elasticity of the skin and delay the skin aging.
In one embodiment, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide and Hyaluronic Acid in a mass ratio of 0.2-1.5 to 1-2 to 0.05-0.1 to 0.5-1, and the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide and Hyaluronic Acid in a mass ratio of 0.5:1.5:0.1:0.8, and the moisturizer comprises aluminum pyrrolidone carboxylate, sodium lactate, ceramide and Hyaluronic Acid in a mass ratio of 0.1-0.5 to 0.2-1.5 to 1-2 to 0.05-0.1 to 0.5-1, and the Hyaluronic Acid in a mass ratio of 0.2:0.5:1.5: 0.8, wherein the moisturizer comprises aluminum pyrrolidone carboxylate, sodium lactate, ceramide and Hyaluronic Acid in a mass ratio of 0.2:0.5: 0.1:0.8, and the Hyaluronic Acid is capable of maintaining the skin roughness and the skin roughness after the skin is aged, and the skin is more easily wrinkled and HAs a dry or wrinkled skin-aged, the skin roughness caused by the addition of a high Hyaluronic Acid-polysaccharide.
In one embodiment, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid and collagen in a mass ratio of 0.2-1.5 ": 1-2": 0.05-0.1 ": 0.5-1": 1-4 ". For example, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid and collagen in a mass ratio of 0.5:1.5:0.1:0.8: 1.5. For another example, the moisturizer comprises 0.1-0.5 mass percent of aluminum pyrrolidone carboxylate, 1-2 mass percent of sodium pyrrolidone carboxylate, 0.05-0.1 mass percent of sodium pyrrolidone carboxylate, 0.5-1 mass percent of sodium pyrrolidone carboxylate, 1-4 mass percent of ceramide, hyaluronic acid and collagen. For example, the moisturizer comprises aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid and collagen in a mass ratio of 0.2:0.5:1.5:0.1:0.8: 1.5. Collagen is a biological macromolecule, the main component in the connective tissue of animals, and is also the functional protein with the largest content and the widest distribution in the mammal body, accounting for 25% -30% of the total protein amount, some organisms even reach more than 80%, the collagen is similar to the structure of human skin collagen, is water-insoluble fibrous glycoprotein, contains a large amount of amino acids and hydrophilic groups in the molecule, has certain surface activity and good compatibility, and has quite good moisturizing effect because the molecule contains a large amount of hydroxyl groups. At a relative humidity of 70%, it can still retain 45% of its own weight of moisture. Collagen has good biocompatibility, biodegradability and bioactivity, and thus is widely used in the fields of food, medicine, tissue engineering, cosmetics, and the like.
In one embodiment, the moisturizer further comprises chondroitin sulfate (Chondrotinsulfate), which has good moisturizing properties. The irritation is very small; in one embodiment, the humectant comprises the following components in a mass ratio of 0.2-1.5 ': 1-2': 0.05-0.1 ': 0.5-1': 0.2-0.9, 1-4, sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen. For example, the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 0.5:1.5:0.1:0.8:0.5: 1.5. For another example, the moisturizer comprises 0.1-0.5, 0.2-1.5, 1-2, 0.05-0.1, 0.5-1, 0.2-0.9, 1-4 of aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen. For example, the moisturizer comprises aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 0.2:0.5:1.5:0.1:0.8:0.5: 1.5. In practical application, collagen can be obtained from aquatic product processing waste such as skin, bone and scale, and chondroitin sulfate can be obtained from animal cartilage.
Furthermore, the humectant comprises glycerol which is commonly called glycerin, is colorless, transparent, odorless and viscous liquid, tastes sweet, has hygroscopicity, and is safe and nontoxic to human bodies; for example, in one embodiment, the humectant further comprises isoprene glycol, and the mass ratio of the isoprene glycol to the glycerol is 1: "1-10". The isopentyl diol is 3-methyl-1, 3-butanediol, has no toxic or side effect on human bodies, and has excellent moisturizing effect when being used together with glycerol. For example, the humectant comprises isoprene glycol and glycerol in a mass ratio of 1:1, 1:2, 1:5, or 1: 10. In one embodiment, the humectant comprises the following components in a mass ratio of 10-100 ': 0.2-1.5 ': 1-2 ': 0.05-0.1 ': 0.5-1 ': 0.2-0.9, 1-4 of glycerol, sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen. For example, the moisturizer comprises glycerol, sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 10:0.5:1.5:0.1:0.8:0.5: 1.5. For another example, the moisturizer comprises glycerol, aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 10-100, 0.1-0.5, 0.2-1.5, 1-2, 0.05-0.1, 0.5-1, 0.2-0.9, 1-4. For example, the moisturizer comprises glycerol, aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 15:0.2:0.5:1.5:0.1:0.8:0.5: 1.5. In one embodiment, the humectant comprises the following components in a mass ratio of (2-8)/(10-100)/(0.2-1.5)/(1-2)/(0.05-0.1)/(0.5-1): 0.2-0.9, 1-4 of isoprene glycol, glycerol, sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen. For example, the moisturizer comprises isoprene glycol, glycerol, sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 2:10:0.5:1.5:0.1:0.8:0.5: 1.5. For another example, the moisturizer comprises 2-8 mass percent, 10-100 mass percent, 0.1-0.5 mass percent, 0.2-1.5 mass percent, 1-2 mass percent, 0.05-0.1 mass percent, 0.5-1 mass percent, 0.2-0.9 mass percent, 1-4 mass percent of isoprene glycol, glycerol, pyrrolidone carboxylic acid aluminum, pyrrolidone carboxylic acid sodium, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen. For example, the moisturizer comprises isoprene glycol, glycerol, aluminum pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, chondroitin sulfate and collagen in a mass ratio of 4:15:0.2:0.5:1.5:0.1:0.8:0.5: 1.5. The stem cell lotion with the proportion is small in skin irritation, generally suitable for skin of various skin types, has a good moisturizing effect by adopting the proportion design of combining the epidermal humectant and the dermal humectant, can realize whitening and other effects, and has a certain antibacterial effect.
In one embodiment, the component B further comprises a Syringa OBLATA extract, Nelumbo NUCIFERA oil, Nelumbo NUCIFERA root powder and Cordyceps sinensis extract, and the mass ratio of the Cladonia lanceolata extract, Syringa OBLATA (Syringa OBLATA Affinis) extract, Nelumbo major (Nelumbo specium) flower oil, Nelumbo NUCIFERA root powder and Cordyceps sinensis (Cordycepssinesis) extract is 4-8: "1-4": 1-3 ": 0.5-1". For example, in the component B, the mass ratio of the cladosporium asteroides extract, the lilac extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract is 5-7 to 2-3 to 1.5-2.5 to 0.6-0.9. For example, in the component B, the mass ratio of the cladosporium asteroides extract, the lilac extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract is 6:3:2:2: 1; for example, the component B comprises cladocera asteroides extract, excrementum passeris extract, lotus flower oil, lotus root powder and cordyceps sinensis extract, wherein the mass ratio of the cladocera asteroides extract, excrementum passeris extract, lotus flower oil, lotus root powder and cordyceps sinensis extract in the component B is 4-8, 1-4, 1-3, 0.5-1, and the total mass ratio of the component B is 10-15. For example, the stem cell toning lotion comprises 60 parts of a component A, 14 parts of a component B and 0.12 part of a component C, wherein the component B comprises 6 parts of cladosporium asterum extract, 3 parts of excrementum passeris extract, 2 parts of lotus flower oil, 2 parts of lotus root powder and 1 part of cordyceps sinensis extract, and the mass ratio of the cladosporium asterium extract, the excrementum passeris extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract in the component B is 6:3:2:2: 1; the rest of the examples are analogized. For another example, in the component B, the mass ratio of the cladosporium asteroides extract, the excrementum passeris extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract is 5:2:2:2: 0.8. Further, in the component B, the mass ratio of the lotus flower oil to the lotus root powder is 1:1. Further, in the component B, the mass ratio of the excrementum passeris extract, the lotus oil and the lotus root powder is 1:1:1. The stem cell lotion prepared according to the proportion has small irritation to skin, is generally suitable for skin of different skin types, and can achieve the technical effects of resisting wrinkles, repairing epidermis and regenerating skin.
For example, a method for preparing stem cell toning lotion comprises the following steps: the component A, the component B and the component C according to any embodiment are prepared and then mixed evenly. For example, as shown in fig. 1, a method for preparing stem cell astringent includes the following steps: adding 55-95 parts of water in the component A into a container, then adding 55-95 parts of a humectant in the component A into the container, wherein the mass ratio of the humectant to the water is 7:60, and primarily mixing uniformly to obtain a mixture of the component A; sequentially adding the cladosporium asteroides extract, the excrementum passeris extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract in 10-15 parts of the component B into the mixture of the component A to obtain a mixture of the component A and the component B, wherein the mass ratio of the cladosporium asteroides extract, the excrementum passeris extract, the lotus flower oil, the lotus root powder and the cordyceps sinensis extract in the component B is 6:3:2:2: 1; adding 0.05-0.2 part of the component C into the mixture of the component A and the component B, and uniformly mixing to obtain the stem cell toning lotion, wherein the rest examples are similar. Further, after the component A, the component B and the component C in any embodiment are mixed uniformly, namely, after the components in any embodiment are mixed uniformly, the preparation method of the stem cell toning lotion further comprises the following steps: and (6) packaging. For example, the product is packaged in bottles of 50 mL. For another example, after the components of the stem cell astringent are mixed uniformly and before being packaged, the preparation method further comprises the following steps: standing; for example, the mixture is left standing for 12 to 48 hours. Thus, according to different components of the stem cell lotion in any embodiment, the stem cell lotion corresponding to any embodiment can be prepared.
In one embodiment, the B component further comprises a Colony Stimulating Factor (CSF) and a tridecapeptide-1, wherein the B component comprises a Scleroderma asteroides extract, a colony stimulating factor and a tridecapeptide-1 in a mass ratio of 4-8 to 0.02 to 0.3, and further comprises a colony stimulating factor of 0.01-0.2, wherein the B component comprises a Scleroderma asteroides extract, a caryophyllacearum extract, a lilac alba extract, lotus root powder, a cordyceps sinensis extract, a cyrtomium fortunei extract and a tridecapetalocystis sp-1 in a mass ratio of 1:1:1:1:1: 1.8, a cyrtomium fortunei extract, a cyrtonema colony stimulating factor of 0.7 to 2, a granulocyte colony stimulating factor of 0.7 to 2, a macrophage-2, and a macrophage-2, wherein the B component further comprises a colony stimulating factor of 0.7, a granulocyte colony stimulating factor of 0.7 to 2, a macrophage stimulating factor of 0.7 to 2, and a macrophage stimulating factor of 0.4 to 2, wherein the CSF and a macrophage stimulating factor of 0.7, the CSF 2, the B component comprises a colony stimulating factor of a granulocyte colony stimulating factor of a macrophage stimulating factor of 0.7, a macrophage stimulating factor of 0.7, a macrophage stimulating factor of a.
In one embodiment, the component B also comprises a lotus rhizome extract, and the mass ratio of the cladosporium asteroides extract to the lotus rhizome extract in the component B is 4-8: 1-2. Further, in the component B, the mass ratio of the lotus root stem extract to the lotus oil to the lotus root powder is 1:1:1. Further, in the component B, the mass ratio of the lotus rhizome extract to the white clove extract to the lotus flower oil to the lotus root powder is 1:1:1:1. For example, the component B comprises cladosporium cucumerinum extract, Syringa oblata extract, Nelumbo nucifera oil, Nelumbo nucifera root powder, Nelumbo nucifera stem extract, Cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 4-8, 1-4, 1-3, 1-2, 0.5-1, 0.02-0.3, and 0.01-0.2. For example, the component B comprises cladosporium fortunei extract, lilac extract, lotus flower oil, lotus root powder, lotus rhizome extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 5:4:3:3:2:0.8:0.08: 0.02. For another example, the component B comprises cladosporium cucumerinum extract, lilac alba extract, lotus flower oil, lotus root powder, lotus rhizome extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 6:3:2:2:2:1:0.1: 0.1. For another example, the component B comprises cladosporium asteroides extract, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 7:1.5:1.5:1.5:1:0.6:0.2: 0.2. For another example, the component B comprises cladosporium cucumerinum extract, lilac alba extract, lotus flower oil, lotus root powder, lotus rhizome extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:1:1:1:1:1:0.06: 0.06. For another example, the component B comprises cladosporium asteroides extract, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:4:2.8:2.7:1.8:0.9:0.2: 0.15. Other embodiments are analogized.
In each embodiment, the component B also comprises a purslane (Portulaca OLERACEA) extract, and the mass ratio of the Cladosiphon stardanum extract to the purslane extract is 4-8: 1-2. For example, the component B comprises cladosporium fortunei extract, Syringa oblata extract, Lotus flower oil, Lotus root powder, Portulaca oleracea extract, Cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 4-8, 1-4, 1-3, 0.5-1, 0.02-0.3, 0.01-0.2. For another example, the component B comprises cladosporium fortunei extract, Syringa oblata extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, Cordyceps extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 4-8, 1-4, 1-3, 1-2, 0.5-1, 0.02-0.3 and 0.01-0.2. For example, the component B comprises cladosporium fortunei extract, lilac extract, lotus flower oil, lotus root powder, lotus rhizome extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 5:4:3:3:2:1:0.8:0.08: 0.02. For another example, the component B comprises cladosporium asteroides extract, Syringa oblata extract, lotus flower oil, lotus root powder, lotus rhizome extract, purslane extract, Cordyceps extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 6:3:2:2:2:1.2:1:0.1: 0.1. For another example, the component B comprises cladosporium cucumerinum extract, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 7:1.5:1.5:1.5:1:1.2:0.6:0.2: 0.2. For another example, the component B comprises cladosporium asteroides extract, lilac extract, lotus flower oil, lotus root powder, lotus rhizome extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:1:1:1:1:1.5:1:0.06: 0.06. For another example, the component B comprises cladosporium cucumerinum extract, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:4:2.8:2.7:1.8:1.5:0.9:0.2: 0.15. Other embodiments are analogized.
In one embodiment, the component B also comprises nicotinamide, and the mass ratio of the cladosporium asteroides extract to the nicotinamide is 4-8: 0.2-1. Nicotinamide (niacinamide), also known as nicotinamide, is an amide compound of nicotinic acid. It is a white crystalline powder; no or almost no odor, bitter taste; it is slightly hygroscopic. It is easily soluble in water or ethanol, and soluble in glycerol. For example, the component B comprises cladosporium fortunei extract, nicotinamide, Syringa alba extract, lotus oil, Lotus root powder, purslane extract, Cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 4-8, 0.2-1, 1-4, 1-3, 1-2, 0.5-1, 0.02-0.3, and 0.01-0.2. For another example, the component B comprises cladosporium cucumerinum extract, nicotinamide, lilac alba extract, lotus oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 4-8, 0.2-1, 1-4, 1-3, 1-2, 0.5-1, 0.02-0.3 and 0.01-0.2. For example, the component B comprises cladosporium fortunei extract, nicotinamide, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 5:0.3:4:3:3:2:1:0.8:0.08: 0.02. For another example, the component B includes cladosporium cucumerinum extract, nicotinamide, lilac alba extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 6:1:3:2:2:2:1.2:1:0.1: 0.1. For another example, the component B comprises cladosporium cucumerinum extract, nicotinamide, lilac alba extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 7:0.5:1.5:1.5:1.5:1:1.2:0.6:0.2: 0.2. For another example, the component B includes cladosporium cucumerinum extract, nicotinamide, lilac alba extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:0.8:1:1:1:1:1.5:1:0.06: 0.06. For another example, the component B comprises cladosporium cucumerinum extract, nicotinamide, lilac alba extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:0.2:4:2.8:2.7:1.8:1.5:0.9:0.2: 0.15. Other embodiments are analogized.
In each embodiment, the component B further comprises a parsley seed extract and/or a grape seed extract, for example, the component B further comprises the parsley seed extract, and the mass ratio of the parsley seed extract to the lilac alba extract is 0.6-1.2: 1-4. For example, the mass ratio of the celery seed extract to the white clover extract is 0.8-1 to 1.2-3.5; for example, the mass ratio of the parsley seed extract to the lilac extract is 0.8:1.5 or 1: 4. And/or the component B also comprises a grape seed extract, and the mass ratio of the grape seed extract to the lilac formosana extract is 0.6-1.2: 1-4. For example, the mass ratio of the grape seed extract to the white cloves extract is 0.8-1 to 1.2-3.5; for example, the mass ratio of the grape seed extract to the lilac extract is 0.8:1.6 or 1: 4. In each embodiment, the component B also comprises a cacao basjoo (Paullinia CUPANA) seed extract, and the mass ratio of the cacao seed extract to the lilac formosana seed extract is 0.5-1: 1-4. For example, the mass ratio of the guarana seed extract to the lilac extract is 0.6-0.8 to 1.2-3.5; for example, the mass ratio of the guarana seed extract to the lilac extract is 0.6:1 or 0.5: 4. Further, in each embodiment, the component B also comprises a schizosaccharomyces cerevisiae fermentation product lysate (BIFIDA FERMENT LYSATE), and the mass ratio of the schizosaccharomyces cerevisiae fermentation product lysate to the lilac formosana extract is 0.05-0.12 to 1-4. For example, the mass ratio of the schizosaccharomyces cerevisiae fermentation product lysate to the lilac extract is 0.06-0.08 ": 1.2-3.5"; for example, the mass ratio of the schizosaccharomyces cerevisiae fermentation product lysate to the lilac alba extract is 0.06:1 or 0.08: 4. In each embodiment, the component B also comprises farnesol, and the mass ratio of the farnesol to the white clove extract is 0.05-0.12 to 1-4. For example, the mass ratio of the farnesol to the white clove extract is 0.06-0.08 to 1.2-3.5; for example, the weight ratio of farnesol to the lilac extract is 0.06:1 or 0.08: 4. In each embodiment, the component B also comprises lauric acid and myristic acid, and the mass ratio of the lauric acid, the myristic acid and the excrementum passeris extract is 0.04-0.08 to 1-4. Lauric acid and myristic acid are slightly irritating and may induce pox, so the dosage is not suitable to be too high. For example, the mass ratio of the lauric acid, the myristic acid and the white clove extract is 0.05-0.07 to 1-4. For another example, the mass ratio of the lauric acid, the myristic acid and the excrementum passeris extract is 0.06:0.06 and 1-4. Further, in each embodiment, the component B further comprises lauric acid and myristic acid, and the mass ratio of the lauric acid to the myristic acid is 1:1.
In addition, the stem cells are not directly differentiated to generate terminally differentiated cells but are first differentiated to transiently expanded cells (cells) which have the ability to generate terminally differentiated cells, and thus can be understood as committed progenitors (cells) which have the lifelong self-renewal capacity after undergoing ten-several unequal divisions, and are further differentiated to differentiate into a plurality of post-mitotic cells (post-mitotic cells) and finally integrated into differentiated cells (cells) which are further differentiated to a plurality of progeny cells by a plurality of differentiation factors after undergoing a few times of differentiation, and are further differentiated to post-mitotic cells (stem-cells) and finally integrated into differentiated cells (cells) which are usually integrated into epithelial cells (cells) and are usually integrated into epithelial stem cells) cells, i.e., cells which are not integrated into epithelial stem cells, and are considered to be capable of being subjected to a plurality of cell division after undergoing a number of cell division in vitro, and cell regeneration, and are usually considered to be subjected to a number of cell regeneration after two cell differentiation processes of epithelial stem cells, i.e., cell regeneration, a number of epithelial stem cells are expressed in vitro, and are considered to be a number of epithelial cell regeneration, and are not to be considered to be a number of cell regeneration of epithelial stem cells of epithelial cell differentiation, and cell regeneration, when two cell regeneration of epithelial stem cells of epithelial cells, the cell growth factors of epithelial cells, the cell growth of epithelial stem cells of epithelial cells in vitro, the same as a cell growth factor, the cell growth factor of epithelial cells, the cell growth of epithelial cells, the same as the cell growth factor of cells of epithelial cells, the same as no cell growth of cells, the cell growth of cells of epithelial cells of epithelial cells of cells, the cells of epithelial cells of mice, the cells of epithelial cells of mice, the cells of mice, the cells of the mice, the cells of the mice, the cells of the mice, the.
In one embodiment, the stem cell lotion further comprises a cosmetic article for being wetted by the blended components; for example, in use, the blended components of the stem cell lotion of any of the above examples are applied or sprayed or extruded onto a cosmetic article, such as a cotton pad, and the cosmetic article, such as a cotton pad, is then applied to the skin. It is noted that the present invention has embodiments of the cosmetic article for being wetted by the blended components, including portions or all of the cosmetic article being wetted by the blended components, i.e., portions or all of the cosmetic article being wetted by the blended components. For example, the cosmetic article includes a cosmetic cotton pad for being wetted by the blended components. For example, the cosmetic cotton is a commercially available product or a self-made product; for example, the cosmetic cotton is fiber cosmetic cotton, and the cosmetic cotton is fiber cosmetic cotton such as silk, all cotton, terylene, blended yarn, tencel and/or biological fiber. Further, the cosmetic article comprises a cosmetic cotton, a cosmetic cotton storage structure, a cosmetic cotton conveying structure, a cosmetic water storage structure and a cosmetic water output structure; wherein the cosmetic cotton is used to be wetted by the blended components. Each component of the stem cell toning lotion is a liquid part, namely, a mixed solution or a mixture of various components A, B and C of the stem cell toning lotion is a liquid part, a cosmetic object of the stem cell toning lotion is a solid part, and the solid part and the liquid part can be separately produced and manufactured respectively, so that convenience is brought to manufacturers; and the stem cell toning lotion can be produced and sold as a complete product. Further, the cosmetic article comprises a plurality of cosmetic pads, each cosmetic pad is stored in the cosmetic pad storage structure, for example, the cosmetic pads are sequentially stacked and stored in the cosmetic pad storage structure; the uniformly mixed components of the stem cell toning lotion, namely the uniformly mixed A component, B component and C component (namely the liquid part of the stem cell toning lotion) of the stem cell toning lotion are stored in the toning lotion storage structure; the cosmetic cotton conveying structure is connected with the cosmetic cotton storage structure and is used for conveying the cosmetic cotton stored in the cosmetic cotton storage structure out one by one; the toning lotion output structure is connected with the toning lotion storage structure and is used for gradually releasing the liquid part of the stem cell toning lotion stored in the toning lotion storage structure. Therefore, when the user uses the stem cell lotion, the user only needs to adopt the lotion delivery structure to output one from the lotion storage structure, then adopts the lotion output structure to release part of the liquid part of the stem cell lotion from the lotion storage structure to the lotion, so that the lotion containing the liquid part of the stem cell lotion can be obtained immediately, the use is very convenient, the irritation to the skin is small, the lotion is generally suitable for the skins of different skin types, the technical effects of resisting wrinkles, repairing the skin and regenerating the skin can be achieved, and the lotion can be used for a long time, beautify the skin and delay aging.
In one embodiment, the cosmetic cotton is granular compressed fiber cosmetic cotton, and the granular compressed fiber cosmetic cotton comprises disc-shaped, spherical, spheroidal, ellipsoidal, capsule-shaped, cylindrical and/or prismatic compressed fiber cosmetic cotton; the invention and the embodiments thereof do not limit how and how much the cosmetic cotton is compressed, and only the cosmetic cotton needs to be compressed into the granular shape so as to be convenient for carrying and using. For example, the cosmetic cotton storage structure comprises a storage cavity and an opening structure thereof, the storage cavity accommodates each granular compressed fiber cosmetic cotton, the opening structure is communicated with the cosmetic cotton conveying structure, the cosmetic cotton conveying structure is used for controlling the opening or closing of the opening structure, outputting one cosmetic cotton when the opening structure is opened, and closing the storage cavity when the opening structure is closed so as to obtain a better storage effect. For another example, the cosmetic cotton conveying structure is further provided with an elastic push-out structure in the storage cavity, and the elastic push-out structure is used for outputting one cosmetic cotton when the opening structure is opened, for example, the elastic push-out structure includes a spring and a top cover, one end of the spring is fixed to one end of the storage cavity of the cosmetic cotton storage structure, the other end of the spring is fixed to the top cover, and the storage cavity accommodates each granular compressed fiber cosmetic cotton between the top cover and the opening structure; in one embodiment, the granular compressed fiber cosmetic cotton is in a disc shape, and the cosmetic cotton conveying structure is used for controlling the opening structure to open to output only one piece of the granular compressed fiber cosmetic cotton when controlling the opening structure to open, so that the opening structure is opened to output one piece of the cosmetic cotton, namely one piece of the granular compressed fiber cosmetic cotton. For example, the cosmetic cotton storage structure is in a strip shape, and the cosmetic cotton storage structure is provided with a strip-shaped storage cavity; the specific design of the cotton wool storage structure and the cotton wool conveying structure can refer to the existing candy or chewing gum packaging structure, such as Yida, Qingzui or Mantussi packaging structures. For example, the elongated storage cavity comprises a plurality of chambers, and each chamber is used for accommodating one granular compressed fiber cosmetic cotton; for another example, the cosmetic cotton storage structure has an annular storage cavity, for example, the annular storage cavity includes a plurality of chambers, and each chamber accommodates one of the granular compressed fiber cosmetic cotton; the opening structure is arranged on the annular storage cavity in a sliding mode and used for enabling the granular compressed fiber cosmetic cotton in one chamber to be in a removable state when the opening structure is opened; for another example, each of the chambers is provided with an elastic pushing-out structure, the elastic pushing-out structure is used for popping out the granular compressed fiber cosmetic cotton in the chamber when the opening structure is opened, for example, the elastic pushing-out structure comprises a spring and a top cover, one end of the spring is fixed at one end of the chamber, the other end of the spring is fixed at the top cover, and the chamber of the storage cavity accommodates a granular compressed fiber cosmetic cotton between the top cover and the opening structure; therefore, when the cosmetic cotton is used, the granular compressed fiber cosmetic cotton in the cavity can be automatically ejected out by sliding the opening structure to a certain cavity position and opening the opening structure; for example, the opening structure is in communication with the cotton wool transfer structure such that opening the opening structure automatically ejects the particulate compressed fibrous cotton wool from the chamber into the cotton wool transfer structure. For example, the cotton pad delivery structure is a delivery conduit.
In one embodiment, the lotion storage structure is provided with a liquid storage cavity and an opening part thereof, and the liquid part of the stem cell lotion is stored in the liquid storage cavity of the lotion storage structure; for example, the liquid part of the stem cell toning water is filled or conveyed into the liquid storage cavity from the opening part; the toning lotion output structure is fixed at the opening part of the toning lotion storage structure and is used for gradually releasing the liquid part of the stem cell toning lotion stored in the toning lotion storage structure through the opening part. Therefore, the user can conveniently supplement the liquid part of the stem cell lotion in the lotion storage structure, thereby being beneficial to prolonging the service life of the product and realizing the effects of environmental protection and energy conservation. For example, the cosmetic water output structure is provided with a pressing type spray head and a connecting pipe thereof, one end of the connecting pipe is connected with the pressing type spray head, and the other end of the connecting pipe is arranged in the liquid storage cavity and is adjacent to the bottom of the cosmetic cotton storage structure; for example, the push-type nozzle is screwed to the opening. For example, the push-type sprayer and the connecting pipe can be designed similarly to the existing air injection or spraying structure, such as Liushen toilet water, Baidobang spray or Anli mouth refreshing spray. Therefore, the liquid part of the appropriate amount of stem cell toning lotion can be sprayed to wet the cosmetic cotton by controlling the pressing type spray head, for example, pressing the pressing type spray head every time, and then the cosmetic cotton is used on the skin, so that the use is very convenient.
In one embodiment, the cosmetic article further comprises a receiving structure, one end of the receiving structure is connected with the cosmetic cotton conveying structure, and the conveying direction of the cosmetic water output structure faces the receiving structure; the receiving structure is used for receiving the cosmetic cotton conveyed by the cosmetic cotton conveying structure and receiving the liquid part of the stem cell cosmetic water conveyed by the cosmetic water output structure, so that the liquid part of the stem cell cosmetic water conveyed by the cosmetic water output structure wets the cosmetic cotton. For example, the end of the receiving structure connected with the cotton pad conveying structure is thinner, and the end of the receiving structure far away from the cotton pad conveying structure is larger, so that the cotton pads conveyed out by the cotton pad conveying structure can be smoothly conveyed on the receiving structure; preferably, the receiving structure comprises a receiving groove and a cover body, and the cover body is covered on the receiving groove; for example, the cover body is arranged on the receiving groove in a covering mode and seals the receiving groove; for example, the cover body is pivoted to the receiving groove or the cover body is slidably arranged on the receiving groove; the cosmetic cotton conveying structure is connected to one end of the receiving groove, the other end of the receiving groove is connected with the cosmetic water output structure, the conveying direction of the cosmetic water output structure faces the receiving groove, namely the conveying direction of the cosmetic water output structure faces the other end of the receiving groove, so that the cosmetic cotton conveyed out by the cosmetic cotton conveying structure can be conveyed into the receiving groove stably, the liquid part of the stem cell cosmetic water conveyed out by the cosmetic water output structure is conveyed into the receiving groove, for example, the liquid part of the stem cell cosmetic water conveyed out by the cosmetic water output structure is sprayed into the receiving groove, and then a user uncovers the cover body to take the cosmetic cotton wetted by the liquid part of the stem cell cosmetic water. For example, the receiving groove is a partial hollow cylinder structure, that is, a remaining structure of the hollow cylinder after being cut off; for another example, the receiving groove is a partial hollow sphere structure, that is, a remaining structure of the hollow sphere after a part of the hollow sphere is cut off; if again, accept the structure and still be provided with the sled board, the one end of sled board is connected the lid, sled board middle part pin joint in accept the side of groove, the other end activity of sled board sets up and is located accept the inside of groove, like this, the cotton transport structure of makeup is carried out the cotton makeup can be carried steadily and is in accept in the groove and be located on the sled board, the liquid part of the stem cell lotion that the lotion output structure carried out sprays to it is moist in accepting the groove cotton makeup, the user is opening during the lid, the other end of sled board is by the linkage perk to be convenient for the user to take the wet cotton makeup of the liquid part of being done cell lotion. In one embodiment, the pry plate is arranged in the receiving groove, and the pry plate is matched with the receiving groove in shape and used for being arranged inside the receiving groove or at the bottom of the receiving groove in an abutting mode; for another example, the part of the prying plate in the receiving groove has a grid structure, and the bottom of the receiving groove is communicated with the space on the prying plate through the grid structure, so that when the liquid part of the stem cell lotion delivered by the lotion output structure is sprayed into the receiving groove, the liquid part of the stem cell lotion received at the bottom of the receiving groove can penetrate into the cotton pads on the prying plate through the grid structure. In one embodiment, the portion of the pry plate in the receiving groove includes a hard skeleton portion and a flexible net structure, the shape of the hard skeleton portion is matched with the shape of the receiving groove, for example, the hard skeleton portion matches with the shape of the receiving groove to form an arc shape or a plane shape, and the flexible net structure is fixedly arranged above the hard skeleton portion, so that the pry plate can be made lighter, and the liquid portion of the stem cell lotion received by the bottom of the receiving groove can be more fully utilized, and waste is avoided.
Furthermore, in each embodiment, the cosmetic article further includes a heating structure, the receiving groove is further provided with a heat conduction portion, and the heating structure is used for heating the heat conduction portion when power is supplied, for example, electric energy is obtained through a battery or a mains supply, so that the liquid part of the stem cell lotion in the heat conduction portion and the cosmetic cotton soaked by the liquid part of the stem cell lotion are slightly heated, for example, the temperature is raised to 29-35 ℃, and thus, a better skin moistening effect can be obtained, and meanwhile, better effects of resisting wrinkles, repairing epidermis and regenerating skin are achieved. Further, the heating structure is linked with the lotion output structure, so that when the lotion output structure conveys the liquid part of the stem cell lotion to the receiving groove, the heating structure heats the heat conducting part, for example, the heating structure is linked with the lotion output structure, so that when the lotion output structure conveys the liquid part of the stem cell lotion to the receiving groove, the heating structure heats the heat conducting part for a preset time, so that the liquid part of the stem cell lotion in the heat conducting part and the cotton pads soaked by the liquid part of the stem cell lotion are heated to 29-35 ℃.
In one embodiment, the cosmetic article further comprises a supporting structure, the cotton wool storage structure and the lotion storage structure are respectively fixed on the supporting structure, one end of the cotton wool conveying structure is arranged on the cotton wool storage structure, the other end of the cotton wool conveying structure is connected with one end of the receiving structure, the cotton wool conveying structure is used for conveying the cotton wool stored in the cotton wool storage structure out one by one, one end of the lotion output structure is connected with the lotion storage structure, the other end of the lotion output structure faces the receiving structure, or the other end of the lotion output structure is connected with the other end of the receiving structure, and the liquid part of the dry cell lotion at the other end of the lotion output structure faces the inside of the receiving structure, the toning lotion output structure is used for gradually releasing the liquid part of the stem cell toning lotion stored in the toning lotion storage structure, and the receiving structure is used for receiving the liquid part of the stem cell toning lotion released by the toning lotion output structure; for example, each time a liquid portion of a range of stem cell lotions is squeezed or squirted out onto or into the receiving structure or into the interior of the receiving structure, e.g., the receiving tank; for example, the amount may be in the range of 1 to 5 mL. For another example, the receiving structure is fixed to the support structure; for another example, the receiving structure is fixed on the supporting structure and is located between the cosmetic cotton storage structure and the cosmetic water storage structure. Thus, the stem cell lotion or the cosmetic article thereof can be designed as a set of integral products to be sold integrally.
For example, the cosmetic cotton storage structure and the cosmetic water storage structure are respectively arranged on the supporting structure, the cosmetic cotton conveying structure is arranged on the cosmetic cotton storage structure, and the cosmetic water output structure is arranged on the cosmetic water storage structure; for example, one end of the cosmetic cotton conveying structure is communicated with the storage cavity of the cosmetic cotton storage structure through the opening structure, and the other end of the cosmetic cotton conveying structure is connected with one end of the receiving structure; for example, one end of the lotion output structure is connected to the reservoir chamber of the lotion storage structure through the opening, and the other end of the lotion output structure faces the receiving structure.
For example, the cosmetic cotton storage structure and the cosmetic water storage structure are respectively movably arranged on the supporting structure, the cosmetic cotton conveying structure is detachably arranged on the cosmetic cotton storage structure, one end of the cosmetic cotton conveying structure is communicated with the storage cavity of the cosmetic cotton storage structure through the opening structure, the other end of the cosmetic cotton conveying structure is connected with one end of the bearing structure, the cosmetic cotton conveying structure is used for conveying out the cosmetic cotton stored in the cosmetic cotton storage structure one by one, the cosmetic water output structure is detachably arranged on the cosmetic water storage structure, one end of the cosmetic water output structure is connected with the liquid storage cavity of the cosmetic water storage structure through the opening, and the other end of the cosmetic water output structure faces the bearing structure. For example, the cosmetic cotton conveying structure is screwed or clamped on the cosmetic cotton storage structure, and/or the cosmetic water output structure is screwed or clamped on the cosmetic water storage structure.
For another example, the cosmetic article further includes a support structure, the cosmetic cotton storage structure and the lotion storage structure are respectively screwed, clamped or plugged on the support structure, the receiving structure is screwed, clamped or plugged on the support structure, and the receiving structure is located between the cosmetic cotton storage structure and the lotion storage structure. In this way, the components of the makeup article are easy to disassemble and assemble, which is beneficial to supplement the liquid part of stem cell toning lotion and cosmetic cotton or maintain the components of the makeup article.
The invention will now be illustrated by the following examples.
Example 1: the stem cell toning lotion comprises 60 parts of a component A, 12 parts of a component B and 0.1 part of a component C; wherein the component A comprises a humectant and water; the component B comprises Cladosiphon okamuranus extract; and, the C fraction comprises stem cells. The humectant is glycerol, and the water is purified water. The mass ratio of the humectant to the water is 6: 56.
Example 2: the stem cell toning lotion comprises 90 parts of a component A, 13 parts of a component B and 0.12 part of a component C; wherein the component A comprises a humectant and water; the component B comprises an cladosporium fortunei extract, a white clove extract, lotus flower oil, lotus root powder and a cordyceps sinensis extract in a mass ratio of 5:2:2:2: 0.8; and, the C component includes epidermal stem cells. The humectant comprises aluminum pyrrolidone carboxylate and sodium pyrrolidone carboxylate, the mass ratio of the aluminum pyrrolidone carboxylate to the sodium pyrrolidone carboxylate is 0.2:0.5, and the water is purified water; the mass ratio of the humectant to the water is 1: 8.
Example 3: the stem cell toning lotion comprises 80 parts of a component A, 14 parts of a component B and 0.08 part of a component C; wherein the component A comprises a humectant and water; the component B comprises cladosporium fortunei extract, white clove extract, lotus flower oil, lotus root powder, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:1:1:1:1:0.06: 0.06; and the component C comprises an epidermal cell growth factor and an epidermal stem cell in a mass ratio of 1: 10. The humectant comprises aluminum pyrrolidone carboxylate, sodium lactate and ceramide at a mass ratio of 0.5:1:2: 0.1. The water is deionized water; the mass ratio of the humectant to the water is 1: 7.
Example 4: stem cell toning lotion, which comprises 65 parts of A component, 11 parts of B component and 0.15 part of C component; wherein the component A comprises a humectant and water; the component B comprises cladoniella asteroides extract, lilac extract, lotus flower oil, lotus root powder, lotus root stem extract, purslane extract, cordyceps sinensis extract, cell colony stimulating factor and tridecapeptide-1 in a mass ratio of 8:1:1:1:1:1.5:1:0.06: 0.06; and, the C component includes epidermal stem cells. The humectant comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide and hyaluronic acid in a mass ratio of 0.5:1.5:0.1: 0.8. The water is deionized water; the mass ratio of the humectant to the water is 1: 12.
Comparative example: purified water.
The facial skin was subjected to continuous trial use using 5 groups of volunteers corresponding to examples 1 to 4 and comparative example, respectively, and the results are shown in the following table.
As can be seen from the above table, examples 1 to 4 are superior to the comparative example in terms of restoration of original appearance and anti-wrinkle effect, and examples 1 to 4 have comparable moisturizing, epidermis-repairing and skin-regenerating effects to the comparative example.
In addition, other embodiments of the present invention further include stem cell lotions that can be implemented and formed by combining the technical features of the above embodiments, wherein the technical features of the embodiments are matched with each other, so that the stem cell lotions have small irritation to the skin, are generally applicable to the skin of various skin types, and can achieve the technical effects of wrinkle resistance, epidermis repair and skin regeneration; and the effects of better moisturizing, whitening and the like can be synergistically realized, and the antibacterial whitening cream has a certain antibacterial effect.
The technical features of the embodiments described above may be arbitrarily combined, and for the sake of brevity, all possible combinations of the technical features in the embodiments described above are not described, but should be considered as being within the scope of the present specification as long as there is no contradiction between the combinations of the technical features.
The above-mentioned embodiments only express several embodiments of the present invention, and the description thereof is more specific and detailed, but not construed as limiting the scope of the invention. It should be noted that, for a person skilled in the art, several variations and modifications can be made without departing from the inventive concept, which falls within the scope of the present invention. Therefore, the protection scope of the present patent shall be subject to the appended claims.
Claims (10)
1. The stem cell toning lotion is characterized by comprising 55-95 parts of a component A, 10-15 parts of a component B and 0.05-0.2 part of a component C; wherein,
the component A comprises a humectant and water;
the component B comprises Cladosiphon okamuranus extract; and the number of the first and second groups,
the C component includes stem cells.
2. The stem cell lotion according to claim 1, wherein the component B further comprises a Syringa oblata extract, Nelumbo nucifera oil, Nelumbo nucifera root powder and Cordyceps sinensis extract, and the mass ratio of the Cladosiphon excisa extract, Syringa oblata extract, Nelumbo nucifera oil, Nelumbo nucifera root powder and Cordyceps sinensis extract in the component B is "4-8": 1-4 ": 1-3": 0.5-1 ".
3. The stem cell lotion according to claim 2, wherein the component B further comprises a cell colony stimulating factor and tridecapeptide-1, and the mass ratio of the Cladosiphon okamuranus extract, the cell colony stimulating factor and the tridecapeptide-1 in the component B is "4-8": 0.02-0.3 ": 0.01-0.2".
4. The stem cell lotion according to claim 3, wherein the component B further comprises a lotus rhizome extract, and the mass ratio of the cladosporium asteroides extract to the lotus rhizome extract in the component B is "4-8": 1-2 ".
5. The stem cell astringent according to any one of claims 1 to 4, wherein in the C component, the stem cells are epidermal stem cells.
6. The stem cell lotion according to claim 5, wherein the mass ratio of the humectant to the water in the component A is "5-10": 50-85 ".
7. The stem cell lotion according to claim 6, wherein the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid, collagen, and/or chondroitin sulfate.
8. The stem cell lotion according to claim 6, wherein the moisturizer comprises sodium pyrrolidone carboxylate, sodium lactate, ceramide, hyaluronic acid and collagen in a mass ratio of "0.2 to 1.5": 1 to 2 ": 0.05 to 0.1": 0.5 to 1 ": 1 to 4".
9. The stem cell lotion according to claim 6, wherein the water in the A-fraction is purified water.
10. The stem cell lotion according to claim 6, wherein the water in the A-component is deionized water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810032109.1A CN108078909A (en) | 2018-01-12 | 2018-01-12 | Stem cell toner |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810032109.1A CN108078909A (en) | 2018-01-12 | 2018-01-12 | Stem cell toner |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108078909A true CN108078909A (en) | 2018-05-29 |
Family
ID=62183181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810032109.1A Withdrawn CN108078909A (en) | 2018-01-12 | 2018-01-12 | Stem cell toner |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108078909A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109998942A (en) * | 2019-04-18 | 2019-07-12 | 上海柳樱商贸有限公司 | A kind of multiple-effect lightening compositions and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853341A (en) * | 2016-05-11 | 2016-08-17 | 广东科玮生物技术股份有限公司 | Anti-aging skincare product containing epidermal stem cell secretin and preparation method of anti-aging skincare product |
-
2018
- 2018-01-12 CN CN201810032109.1A patent/CN108078909A/en not_active Withdrawn
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105853341A (en) * | 2016-05-11 | 2016-08-17 | 广东科玮生物技术股份有限公司 | Anti-aging skincare product containing epidermal stem cell secretin and preparation method of anti-aging skincare product |
Non-Patent Citations (2)
| Title |
|---|
| 王建新等: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社 * |
| 第十届东南亚地区医学美容学术大会论文汇编编委: "《第十届东南亚地区医学美容学术大会论文汇编》", 31 August 2006 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109998942A (en) * | 2019-04-18 | 2019-07-12 | 上海柳樱商贸有限公司 | A kind of multiple-effect lightening compositions and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106176466B (en) | Children's face cream and preparation method thereof | |
| CN103494760B (en) | Moistening and whitening facial mask and preparation method thereof | |
| KR101723845B1 (en) | Natural cosmetic composition of mask pack and method for manufacturing natural cosmetic composition of mask pack | |
| US20170049692A1 (en) | Skin rejuvenation and defense system | |
| CN104382799A (en) | Skin care product having anti-wrinkle firming and beauty-maintaining moisturizing effects | |
| CN106256339A (en) | Multi-functional face cleaning towel containing vegetalitas collagen protein and manufacture method thereof | |
| KR102187653B1 (en) | Freeze dried cosmetics for skin improvement | |
| KR20160144836A (en) | Peel-off pack composition containing rice bran, kaolin and bentonite and method for preparing the same | |
| CN104586740A (en) | Moisturizing beauty mask and preparation method thereof | |
| CN102836110A (en) | Whitening mask | |
| CN110575411A (en) | spray mask composition | |
| CN108078909A (en) | Stem cell toner | |
| CN108042480A (en) | Mildy wash based on foreign Pseudanabaena sp extract | |
| JP6731699B2 (en) | Method of manufacturing chemical composition | |
| CN114796062B (en) | A composition and a compact anti-aging cosmetic | |
| CN108078908A (en) | Spirulina extract stem cell smoothing toner | |
| CN104288049A (en) | Skin-whitening cosmetic formula | |
| CN108030747A (en) | Starfish branch tube algae extract Essence and its use complete product system | |
| CN108485851A (en) | A kind of tea seed handmade soap and the technique for making the tea seed handmade soap | |
| KR102267938B1 (en) | Moisturizing cosmetics that improve skin absorption, including asiatic pennywort extract, anemarrhena asphodeloides root extract, apricot seed oil, and peptides having antioxidant activity, and a method for manufacturing the same | |
| JP3839390B2 (en) | Cosmetics | |
| CN104922007A (en) | Wrinkle-removal essence | |
| KR102081974B1 (en) | Mask pack composition comprising for moisturizing effect and enhancing elasticity on the skin | |
| CN112716863A (en) | Graphene rose essence facial mask and preparation method thereof | |
| CN109125149A (en) | A kind of sodium hyaluronate mildy wash and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180529 |
|
| WW01 | Invention patent application withdrawn after publication |